Marketing-authorisation holder · India
Dr. Reddy's Laboratories Limited
131 medicines in 2 countries, as authorisation holder, manufacturer and marketer.
Loading your page…
Loading your page…
Marketing-authorisation holder · India
131 medicines in 2 countries, as authorisation holder, manufacturer and marketer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 131
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ADRUXE10 mg / ml · Solution | Rituximab | Canada | Authorised | |
| ATORVASTATIN80 mg · Tablet | Atorvastatin | Canada | Authorised | |
| ATORVASTATIN10 mg · Tablet | Atorvastatin | Canada | Authorised | |
| ATORVASTATIN40 mg · Tablet | Atorvastatin | Canada | Authorised | |
| ATORVASTATIN20 mg · Tablet | Atorvastatin | Canada | Authorised | |
| AZACITIDINE FOR INJECTION150 mg / vial · Powder For Suspension | Azacitidine | Canada | Authorised | |
| AZACITIDINE FOR INJECTION100 mg / vial · Powder For Suspension | Azacitidine | Canada | Marketed | 2017 |
| BORTEZOMIB FOR INJECTION3.5 mg / vial · Powder For Solution | Bortezomib | Canada | Marketed | 2017 |
| BORTEZOMIB INJECTION2.5 mg / ml · Solution | Bortezomib | Canada | Marketed | 2025 |
| CABAZITAXEL FOR INJECTION40 mg / ml · Solution | Cabazitaxel | Canada | Marketed | 2020 |
| CARBOPROST TROMETHAMINE INJECTION, USP250 mcg / ml · Solution | Carboprost | Canada | Marketed | 2023 |
| CARBOPROST TROMETHAMINE INJECTION, USP250 mcg / ml · Solution | Carboprost | Canada | Authorised | |
| CYCLOPHOSPHAMIDE FOR INJECTION500 mg / ml · Solution | Cyclophosphamide | Canada | Authorised | |
| DAPTOMYCIN FOR INJECTION500 mg / vial · Powder For Solution | Daptomycin | Canada | Marketed | 2020 |
| ERIBULIN MESYLATE INJECTION0.5 mg / ml · Solution | Eribulin | Canada | Marketed | 2025 |
| ERTAPENEM FOR INJECTION1 g / vial · Powder For Solution | Ertapenem | Canada | Marketed | 2021 |
| ESAMUZE45 mg / ml · Solution | Bendamustine | Canada | Authorised | |
| FONDAPARINUX SODIUM INJECTION5 mg / 0.4 ml · Solution | Fondaparinux | Canada | Authorised | |
| FONDAPARINUX SODIUM INJECTION2.5 mg / 0.5 ml · Solution | Fondaparinux | Canada | Marketed | 2014 |
| FONDAPARINUX SODIUM INJECTION7.5 mg / 0.6 ml · Solution | Fondaparinux | Canada | Marketed | 2014 |
| FONDAPARINUX SODIUM INJECTION10 mg / 0.8 ml · Solution | Fondaparinux | Canada | Authorised | |
| HANZEMA30 mg · Capsule | Alitretinoin | Canada | Marketed | 2021 |
| HANZEMA10 mg · Capsule | Alitretinoin | Canada | Marketed | 2021 |
| OXALIPLATIN INJECTION, USP5 mg / ml · Solution | Oxaliplatin | Canada | Marketed | 2022 |
| PEGYLATED LIPOSOMAL DOXORUBICIN HYDROCHLORIDE FOR INJECTION2 mg / ml · Suspension | Doxorubicin | Canada | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 128 | 103 | 25 | CompaniesAll medicines |
| Spain | 3 | 0 | 3 | CompaniesAll medicines |
Also in the registers of Brazil, Singapore, United Kingdom, United States
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
GLEIF; exact source URLs/locators, version status and retrieval dates. Normalized by Prognia; no official endorsement.
Licence: CC0
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.